Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) : vimarsana.com

Regulatory News: Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric

Related Keywords

Mont Saint Guibert , Waals Gewest , Belgium , New York , United States , Walloon Region , Paris , France General , France , Lincoln Park , Illinois , Brussels , Bruxelles Capitale , Chicago , Belgian , Sara Zelkovic , Filippo Petti , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Company To Lincoln Park Capital Fund , Regulatory News , Euronext Nasdaq , Lincoln Park Capital Fund , Belgian Law , Capital Increase , Chief Executive Officer , Private Securities Litigation Reform Act , Celyad Oncology , Annual Report , Investor Relations Director , Sci Advisors , Celyad , Ncology , Nformation , Otal , Umber , Oting , Ights , Hares , Rticle , 007 ,